Evidence map›Paper›PMID 32832918›Full record

ArticleNature cancer2020

α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer.

Thai Q Tran, Eric A Hanse, Amber N Habowski, Haiqing Li, Mari B Ishak Gabra, Ying Yang, Xazmin H Lowman, Amelia M Ooi, Shu Y Liao, Robert A Edwards and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
7.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 163 citations in OpenAlex.

  1. Review
  2. Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Article
  4. Lactate, Carbohydrate Restriction, and Cancer Metabolism.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The metabolic profiles of cancer stem cells.Stem cell research & therapy · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Thai Q TranDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0001-7559-0525
Eric A Hanse *Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-1234-0198
Amber N Habowski *Department of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA, USA.
Haiqing LiDivision of Informatics, Department of Computational and Quantitative Medicine, Center of Informatics, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0001-5583-2240
Mari B Ishak GabraDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA.
Ying YangDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA.
Xazmin H LowmanDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA.
Amelia M OoiDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA.
Shu Y LiaoDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.
Robert A EdwardsDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.
Marian L WatermanDepartment of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA, USA.
Mei KongDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA. meik1@uci.edu.ORCID http://orcid.org/0000-0001-8139-2349
University of California, Irvine · USCity of Hope · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Shared Resource Core: Single Cell AnalysisU54CA217378 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI VAN ETTEN, RICHARD A. · 2018 to 2022
$9.7M
CARCINOGENESIST32CA009054 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDINGER, AIMEE L, FRUMAN, DAVID ALEXANDER · 1985 to 2025
$8.6M
Cancer Cell Adaption to Glutamine DeprivationR01CA183989 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KONG, MEI · 2014 to 2019
$1.7M
Protein Phosphatase Control of AMPK FunctionR01GM132142 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI KONG, MEI · 2019 to 2023
$1.2M
NCI NIH HHS P30 CA033572NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA183989NCI NIH HHS T32 CA009054NCI NIH HHS U54 CA217378NIGMS NIH HHS R01 GM132142
6 · The paper itself

Abstract

Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumourigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC mutant intestinal organoids to promote stemness and leads to adenocarcinoma formation

Indexed as

Colorectal NeoplasmsWnt Signaling PathwayGlutamineHumansKetoglutaric AcidsOrganoidsTumor MicroenvironmentGlutamineKetoglutaric Acidscancer metabolismcolon cancerepigeneticsglutamineWnt signaling

Identifiers

PMID32832918
PMCPMC7442208
OpenAlexW3012399094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.